We are preparing the requested document. Please wait, this may take a while...!
|Application / Reactivity||Human|
|Cell Culture (CC)||1 Antibodies|
|Cytometry by Time of Flight (CyTOF)||1 Antibodies|
|ELISA (Capture)||1 Antibodies|
|ELISA (Detection)||2 Antibodies|
|Enzyme Immunoassay (EIA)||9 Antibodies|
|Flow Cytometry (FACS)||32 Antibodies|
|Immunochromatography (IC)||1 Antibodies|
|Immunocytochemistry (ICC)||3 Antibodies|
|Immunofluorescence (IF)||10 Antibodies|
|Immunofluorescence (Paraffin-embedded Sections) (IF (p))||26 Antibodies|
|Immunohistochemistry (IHC)||52 Antibodies|
|Immunohistochemistry (Frozen Sections) (IHC (fro))||6 Antibodies|
|Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))||31 Antibodies|
|Immunoprecipitation (IP)||19 Antibodies|
|Intracellular Flow Cytometry (ICFC)||2 Antibodies|
|Western Blotting (WB)||108 Antibodies|
|Antigen||Fms-Related Tyrosine Kinase 4 (FLT4) Antibodies|
|Epitope||AA 25-776 Alternatives|
|Conjugate||This FLT4 antibody is conjugated to Allophycocyanin Alternatives|
Flow Cytometry (FACS)
|5 references available|
|Supplier||Log in to see|
Product Details anti-FLT4 AntibodyTarget Details FLT4 Application Details Handling References for anti-FLT4 Antibody (ABIN4896918) Images
|Specificity||Detects human VEGF R3/Flt-4 in direct ELISAs.|
|Purification||Protein A or G purified from hybridoma culture supernatant|
|Immunogen||Mouse myeloma cell line NS0-derived recombinant human VEGF R3/Flt-4, Tyr25-Ile776, Accession # P35916|
Target Details FLT4Product Details anti-FLT4 Antibody Application Details Handling References for anti-FLT4 Antibody (ABIN4896918) Images back to top
|Alternative Name||VEGF R3 (FLT4 Antibody Abstract)|
|Background||Alternative Names: EC 2.7.10, EC 18.104.22.168, Flt-4, FLT4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGFR3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4|
|Pathways||RTK Signaling, Signaling Events mediated by VEGFR1 and VEGFR2|
Application DetailsProduct Details anti-FLT4 Antibody Target Details FLT4 Handling References for anti-FLT4 Antibody (ABIN4896918) Images back to top
|Application Notes||Flow Cytometry 10 uL/10^6 cells|
|Restrictions||For Research Use only|
HandlingProduct Details anti-FLT4 Antibody Target Details FLT4 Application Details References for anti-FLT4 Antibody (ABIN4896918) Images back to top
|Buffer||Supplied in a saline solution containing BSA and Sodium Azide.|
|Precaution of Use||This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.|
|Storage Comment||Protect from light. Do not freeze. 12 months from date of receipt,2°C to 8°C as supplied.|
|Expiry Date||12 months|
References for anti-FLT4 Antibody (ABIN4896918)Product Details anti-FLT4 Antibody Target Details FLT4 Application Details Handling Images back to top
|Product cited in:||
Sie, den Dunnen, Lourens, Meeuwsen-de Boer, Scherpen, Zomerman, Kampen, Hoving, de Bont: "Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma." in: PLoS ONE, Vol. 10, Issue 3, pp. e0122555, 2015 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).
Norton, Han, Popel, Pandey: "Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells." in: OncoTargets and therapy, Vol. 7, pp. 1571-82, 2014 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).
Fiorio Pla, Brossa, Bernardini, Genova, Grolez, Villers, Leroy, Prevarskaya, Gkika, Bussolati: "Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib." in: BMC cancer, Vol. 14, pp. 939, 2014 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).
Roorda, Ter Elst, Scherpen, Meeuwsen-de Boer, Kamps, de Bont: "VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms." in: European journal of cancer (Oxford, England : 1990), Vol. 46, Issue 5, pp. 974-82, 2010 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).
Nilsson, Zage, Zeng, Xu, Cascone, Wu, Saigal, Zweidler-McKay, Heymach: "Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors." in: Oncogene, Vol. 29, Issue 20, pp. 2938-49, 2010 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).
ImagesProduct Details anti-FLT4 Antibody Target Details FLT4 Application Details Handling References for anti-FLT4 Antibody (ABIN4896918) back to top